This new application to treat Desminopathy, a progressive muscle disease caused by mutations in the DES gene, uses a dual knockdown and replace approach with microRNA‑based tools to selectively suppress mutant DES mRNA while simultaneously delivering a healthy, codon‑optimized DES sequence via an AAV vector.